Rare Biomarkers Specimen Collection & Stabilization Market by Product Type (Circulating Cell Free DNA, Circulating Tumor Cells, Exosomes or Extracellular Vesicles), Collection Type (Blood Collection Tubes & Systems, Isolation Kits & Reagents), Application

Rare Biomarkers Specimen Collection & Stabilization Market by Product Type (Circulating Cell Free DNA, Circulating Tumor Cells, Exosomes or Extracellular Vesicles), Collection Type (Blood Collection Tubes & Systems, Isolation Kits & Reagents), Application, End Use - Global Forecast 2024-2030


The Rare Biomarkers Specimen Collection & Stabilization Market size was estimated at USD 29.94 billion in 2023 and expected to reach USD 32.21 billion in 2024, at a CAGR 7.54% to reach USD 49.83 billion by 2030.

Global Rare Biomarkers Specimen Collection & Stabilization Market

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Rare Biomarkers Specimen Collection & Stabilization Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Rare Biomarkers Specimen Collection & Stabilization Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Rare Biomarkers Specimen Collection & Stabilization Market, highlighting leading vendors and their innovative profiles. These include ABL, Inc., ACM Global Laboratories, Almac Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioAgilytix Labs, LLC, bioMérieux, Inc., Charles River Laboratories International, Inc., IQVIA Inc., Labcorp Drug Development, NorthEast BioAnalytical Laboratories LLC, PerkinElmer Inc., SGS Société Générale de Surveillance SA, Svar Life Science AB, and Synexa Life Sciences BV.

Market Segmentation & Coverage



This research report categorizes the Rare Biomarkers Specimen Collection & Stabilization Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product Type
Circulating Cell Free DNA
Circulating Tumor Cells
Exosomes or Extracellular Vesicles
Collection Type
Blood Collection Tubes & Systems
Isolation Kits & Reagents
Application
Cardiovascular Diseases
NIPT
Oncology
Pharmacogenomics
Population Screening
Transcriptomics
Transplant Rejection
End Use
Hospitals
Perinatal Clinics
Physician Labs
Private or Commercial Labs
Public Health Labs
Research Institutes
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Rare Biomarkers Specimen Collection & Stabilization Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Rare Biomarkers Specimen Collection & Stabilization Market?
3. What are the technology trends and regulatory frameworks in the Rare Biomarkers Specimen Collection & Stabilization Market?
4. What is the market share of the leading vendors in the Rare Biomarkers Specimen Collection & Stabilization Market?
5. Which modes and strategic moves are suitable for entering the Rare Biomarkers Specimen Collection & Stabilization Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Rare Biomarkers Specimen Collection & Stabilization Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising preference of a non-invasive mode of disease treatment
5.1.1.2. Increasing demand for personalized medicine
5.1.1.3. Growth in number of research studies to depict the role of circulating biomarkers
5.1.2. Restraints
5.1.2.1. Stringent regulations in the industry
5.1.3. Opportunities
5.1.3.1. Innovation of novel assays such as liquid biopsy assays
5.1.3.2. Collaborative initiatives for market developments
5.1.4. Challenges
5.1.4.1. Limited reimbursement scenario
5.1.4.2. Complexities in characterization and ineffective separation protocols
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Rare Biomarkers Specimen Collection & Stabilization Market, by Product Type
6.1. Introduction
6.2. Circulating Cell Free DNA
6.3. Circulating Tumor Cells
6.4. Exosomes or Extracellular Vesicles
7. Rare Biomarkers Specimen Collection & Stabilization Market, by Collection Type
7.1. Introduction
7.2. Blood Collection Tubes & Systems
7.3. Isolation Kits & Reagents
8. Rare Biomarkers Specimen Collection & Stabilization Market, by Application
8.1. Introduction
8.2. Cardiovascular Diseases
8.3. NIPT
8.4. Oncology
8.5. Pharmacogenomics
8.6. Population Screening
8.7. Transcriptomics
8.8. Transplant Rejection
9. Rare Biomarkers Specimen Collection & Stabilization Market, by End Use
9.1. Introduction
9.2. Hospitals
9.3. Perinatal Clinics
9.4. Physician Labs
9.5. Private or Commercial Labs
9.6. Public Health Labs
9.7. Research Institutes
10. Americas Rare Biomarkers Specimen Collection & Stabilization Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Rare Biomarkers Specimen Collection & Stabilization Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Rare Biomarkers Specimen Collection & Stabilization Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. ABL, Inc.
14.1.2. ACM Global Laboratories
14.1.3. Almac Group
14.1.4. Becton, Dickinson and Company
14.1.5. Bio-Rad Laboratories, Inc.
14.1.6. BioAgilytix Labs, LLC
14.1.7. bioMérieux, Inc.
14.1.8. Charles River Laboratories International, Inc.
14.1.9. IQVIA Inc.
14.1.10. Labcorp Drug Development
14.1.11. NorthEast BioAnalytical Laboratories LLC
14.1.12. PerkinElmer Inc.
14.1.13. SGS Société Générale de Surveillance SA
14.1.14. Svar Life Science AB
14.1.15. Synexa Life Sciences BV
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET RESEARCH PROCESS
FIGURE 2. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2023 VS 2030
FIGURE 3. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET DYNAMICS
FIGURE 7. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
FIGURE 8. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2023 VS 2030 (%)
FIGURE 10. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2023 VS 2030 (%)
FIGURE 14. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings